Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas

E. Galanis*, J. Buckner, D. Kimmel, R. Jenkins, B. Alderete, J. O'Fallon, C. H. Wang, B. W. Scheithauer, C. D. James

*Corresponding author for this work

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

The purpose of this study was to examine the incidence of gene amplification in patients with primary (de novo) and secondary high-grade gliomas (gliomas evolving from lower grade malignancies) and to assess its prognostic significance. A total of 186 prospectively collected frozen surgical specimens were analyzed. Extracted DNA was examined by Southern blot using probes corresponding to the EGFR, CDK4, MDM2, N-MYC, CYCD1, PDGFR-α, MET, C-MYC oncogenes. Complete clinical data regarding age, sex, tumor size, extent of surgical resection, postoperative therapy and patient survival were collected. We showed that EGFR followed by CDK4 were the most frequent oncogene amplifications. Oncogene amplification events were significantly more frequent in grade 4 than in grade 3 astrocytomas, mixed gliomas or oligodendrogliomas (P<0.001). With respect to EGFR, there was a significant difference in the frequency of amplification between primary and secondary gliomas (P=0.001); however, no difference in the amplification frequency of the other oncogenes was observed. There was no apparent correlation between the occurrence of gene amplification and patient survival, possibly because the genes amplified in human gliomas are part of larger signaling pathways.

Original languageEnglish (US)
Pages (from-to)717-724
Number of pages8
JournalInternational journal of oncology
Volume13
Issue number4
DOIs
StatePublished - Oct 1998

Keywords

  • Astrocytomas
  • C-MYC
  • CDK4
  • Cyclin D
  • EGFR
  • GBM
  • Gene amplification
  • Gliomas
  • MDM2
  • MET
  • N-MYC
  • PDGFR-α

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas'. Together they form a unique fingerprint.

  • Cite this

    Galanis, E., Buckner, J., Kimmel, D., Jenkins, R., Alderete, B., O'Fallon, J., Wang, C. H., Scheithauer, B. W., & James, C. D. (1998). Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. International journal of oncology, 13(4), 717-724. https://doi.org/10.3892/ijo.13.4.717